MedPath

Combined Korean medicine therapies in children with allergic rhinitis: A multi-center, observational explanatory registry trial.

Not Applicable
Recruiting
Conditions
Diseases of the respiratory system
Registration Number
KCT0006625
Lead Sponsor
Kyung Hee University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

– Aged under 12 years children who visit Ham-soa Korean Medicine clinic for treating AR
– Diagnosis AR with ARIA(Allergic Rhinitis and its Impact on Asthma) criteria
– Intelligible yes/no response.
– Ability to understand simple introductions of Korean explanations Grammar.
– Availability to participate in the investigation duration 8-weeks
– Accessibility to the mobile questionnaire.
– A children or caregiver who agrees to participate and signs the consent form after hearing a clear explanation of the purpose and characteristics of this clinical study

Exclusion Criteria

- Those who are participating in other clinical studies
- Diagnosed with allergic rhinitis, but has history to visit another medical institution and receive treatment for AR within 3 months
- Those who refuse to participate in clinical research or provide consent
- Those who are judged to be inadequate for clinical research or have any other reason deemed inadequate to participate in research by the medical staff.

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Total nasal symptom score, TNSS;Numerical rating scales, NRS
Secondary Outcome Measures
NameTimeMethod
Quality of life questionnaire in Korean children with allergic rhinitis;PedsQLTM 4.0 Generic Core Scale ;Paediatric Allergic Disease Quality of Life Questionnaire; PADQLQ
© Copyright 2025. All Rights Reserved by MedPath